全文获取类型
收费全文 | 3946篇 |
免费 | 326篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 179篇 |
妇产科学 | 93篇 |
基础医学 | 457篇 |
口腔科学 | 85篇 |
临床医学 | 412篇 |
内科学 | 906篇 |
皮肤病学 | 37篇 |
神经病学 | 226篇 |
特种医学 | 393篇 |
外科学 | 385篇 |
综合类 | 127篇 |
预防医学 | 390篇 |
眼科学 | 123篇 |
药学 | 252篇 |
中国医学 | 10篇 |
肿瘤学 | 182篇 |
出版年
2023年 | 25篇 |
2021年 | 51篇 |
2020年 | 22篇 |
2019年 | 60篇 |
2018年 | 57篇 |
2017年 | 52篇 |
2016年 | 47篇 |
2015年 | 65篇 |
2014年 | 94篇 |
2013年 | 155篇 |
2012年 | 173篇 |
2011年 | 143篇 |
2010年 | 129篇 |
2009年 | 146篇 |
2008年 | 165篇 |
2007年 | 191篇 |
2006年 | 137篇 |
2005年 | 150篇 |
2004年 | 152篇 |
2003年 | 123篇 |
2002年 | 114篇 |
2001年 | 110篇 |
2000年 | 113篇 |
1999年 | 95篇 |
1998年 | 123篇 |
1997年 | 83篇 |
1996年 | 89篇 |
1995年 | 85篇 |
1994年 | 72篇 |
1993年 | 78篇 |
1992年 | 75篇 |
1991年 | 71篇 |
1990年 | 74篇 |
1989年 | 96篇 |
1988年 | 81篇 |
1987年 | 74篇 |
1986年 | 66篇 |
1985年 | 66篇 |
1984年 | 52篇 |
1983年 | 38篇 |
1982年 | 27篇 |
1981年 | 35篇 |
1980年 | 30篇 |
1979年 | 34篇 |
1978年 | 35篇 |
1977年 | 27篇 |
1976年 | 31篇 |
1973年 | 27篇 |
1969年 | 29篇 |
1968年 | 22篇 |
排序方式: 共有4286条查询结果,搜索用时 15 毫秒
101.
102.
103.
Rebecca E. Conway Camilo Rojas Jesse Alt Zora Nováková Spencer M. Richardson Tori C. Rodrick Julio L. Fuentes Noah H. Richardson Jonathan Attalla Samantha Stewart Beshoy Fahmy Cyril Barinka Mallika Ghosh Linda H. Shapiro Barbara S. Slusher 《Angiogenesis》2016,19(4):487-500
Prostate-specific membrane antigen (PSMA) is a membrane-bound glutamate carboxypeptidase expressed in a number of tissues. PSMA participates in various biological functions depending on the substrate available in the particular tissue; in the brain, PSMA cleaves the abundant neuropeptide N-acetyl-aspartyl-glutamate to regulate release of key neurotransmitters, while intestinal PSMA cleaves polyglutamated peptides to supply dietary folate. PSMA expression is also progressively upregulated in prostate cancer where it correlates with tumor progression as well as in tumor vasculature, where it regulates angiogenesis. The previous research determined that PSMA cleavage of small peptides generated via matrix metalloprotease-mediated proteolysis of the extracellular matrix protein laminin potently activated endothelial cells, integrin signaling and angiogenesis, although the specific peptide substrates were not identified. Herein, using enzymatic analyses and LC/MS, we unequivocally demonstrate that several laminin-derived peptides containing carboxy-terminal glutamate moieties (LQE, IEE, LNE) are bona fide substrates for PSMA. Subsequently, the peptide products were tested for their effects on angiogenesis in various models. We report that LQ, the dipeptide product of PSMA cleavage of LQE, efficiently activates endothelial cells in vitro and enhances angiogenesis in vivo. Importantly, LQE is not cleaved by an inactive PSMA enzyme containing an active site mutation (E424S). Endothelial cell activation by LQ was dependent on integrin beta-1-induced activation of focal adhesion kinase. These results characterize a novel PSMA substrate, provide a functional rationale for the upregulation of PSMA in cancer cells and tumor vasculature and suggest that inhibition of PSMA could lead to the development of new angiogenic therapies. 相似文献
104.
Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin 总被引:4,自引:0,他引:4
OBJECTIVE Hyperinsulinaemia in the polycystic ovary syndrome (PCOS) has previously been defined using polyclonal radioimmunoassays (RIA) in which partially processed insulin-like molecules cross-react. This study aimed to reassess hyperinsulinaemia in women with PCOS using specific immunoradiometric assays (IRMA) for insulin, proinsulin and 32–33 spilt proinsulin. DESIGN Patients attended for 75 g oral glucose tolerance tests and were divided into groups depending on their degree of obesity and fasting insulin status determined by RIA. IRMA measurements for insulin-like molecules in plasma from patients with PCOS and controls were compared. PATIENTS Thirty-four patients with ultrasound diagnosed PCOS presented to a reproductive endocrinology clinic. A control group comprised women with normal ovaries on ultrasound. Four groups were constructed, two with normal fasting insulin concentrations (lean PCOS and controls) and two with hyperinsulinaemia (lean and obese PCOS). MEASUREMENTS Plasma glucose, insulin (RIA and IRMA), proinsulin and 32–33 split proinsulin concentrations were measured at time 0, 30 and 120 minutes of an oral glucose tolerance test. RESULTS Hyperinsulinaemia determined by RIA in lean and obese women with PCOS was confirmed using a specific IRMA assay for insulin. Plasma proinsulin and 32–33 split proinsulin concentrations were higher in hyper-insullnaemic women with PCOS compared with women with normal insulin concentrations. The proportion of circulating insulin-like molecules represented by proinsulin and 32–33 split proinsulin was similar in all groups studied. CONCLUSIONS Hyperinsulinaemia in PCOS is likely to reflect insulin resistance because the raised concentrations of proinsulin and 32–33 split proinsulin were in proportion to the raised insulin concentrations. Hyperinsulinaemia in PCOS, defined by RIA, therefore differs from that in non-Insulin dependent diabetes mellitus where it Is largely accounted for by disproportionate hyperproinsulinaemla. 相似文献
105.
Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation 总被引:12,自引:0,他引:12
Conway DS Buggins P Hughes E Lip GY 《Journal of the American College of Cardiology》2004,43(11):2075-2082
OBJECTIVES: We sought to test the hypothesis that there is a relationship between inflammation and the prothrombotic state in atrial fibrillation (AF). BACKGROUND: Atrial fibrillation is associated with a prothrombotic or hypercoagulable state, which may contribute to an increased risk of stroke and thromboembolism. Inflammation may be involved in the pathogenesis of AF, but the role of inflammation in the pathophysiology of the prothrombotic state of AF has not been studied in detail, despite evidence of a link between inflammation and arterial atherothrombotic disorders. METHODS: We measured plasma indexes of inflammation (C-reactive protein [CRP] and interleukin-6 [IL-6]) and the prothrombotic state, including markers of platelet activation (soluble P-selectin), endothelial damage/dysfunction (von Willebrand factor), the coagulation cascade (tissue factor [TF], fibrinogen), and indexes of blood rheology (plasma viscosity, plasma fibrinogen, and hematocrit) in 106 patients with chronic AF and 41 healthy control subjects included in a cross-sectional analysis. RESULTS: Compared with controls, AF patients had higher levels of IL-6 (p = 0.034), CRP (p = 0.003), TF (p = 0.019), and plasma viscosity (p = 0.045). Plasma IL-6 levels were higher among AF patients at "high" risk of stroke (p = 0.003). After adjusting for potential confounding clinical variables (e.g., vascular disease), AF remained significantly associated with a raised logarithmic transformation (log) of TF (p = 0.04), but the relationships between AF and log IL-6, log CRP, and plasma viscosity became nonsignificant. Among AF patients, log TF (p < 0.001) and high stroke risk (p = 0.003) were independent associates of log IL-6 (adjusted r(2) = 0.443), whereas log fibrinogen (p < 0.001) and plasma viscosity (p = 0.04) were independent associates of log CRP (adjusted r(2) = 0.259). CONCLUSIONS: Increased plasma IL-6, CRP, and plasma viscosity support the case for the existence of an inflammatory state among "typical" populations with chronic AF. These indexes of inflammation are related to indexes of the prothrombotic state and may be related to the clinical variables of the patients (underlying vascular disease and co-morbidities), rather than simply to the presence of AF itself. 相似文献
106.
The possibility that chlorothiazide affects the hypertensive process is a very real one since the effect on the blood pressure of long term treatment is to reduce peripheral resistance.
The means by which this is achieved is unknown. It cannot be shown to be due to loss of sodium since the level of exchangeable sodium returns to normal on long term treatment. The only change we have been able to observe is a fall in total body water which is believed to be due to a loss of cellular water. 相似文献
107.
BACKGROUND: It has previously been shown that testosterone implantation is an effective and well accepted form of androgen replacement therapy, but that pellet extrusion was the most frequent side-effect. The present study aimed to reduce the extrusion rate. OBJECTIVE: To determine whether the washing of testosterone pellets to remove potentially surface-adherent particles decreased the rate of extrusion of pellet implants. DESIGN: Prospective, randomized parallel group design in a single centre with consecutive procedures to be randomized (1 : 1) into a wash or control group. PATIENTS: The study included 251 testosterone implantation procedures in men with known androgen deficiency. MEASUREMENTS: The primary endpoint, extrusion rate per procedure, was evaluated prospectively by telephone contact at 1 week and then 3 and 6 month intervals. Secondary end-points included peri-procedure adverse events (bleeding, skin reaction, excessive discomfort) noted at the time of implant. Bruising, bleeding and infection were also evaluated as later adverse events by telephone and personal follow-up. Explanatory variables recorded as possible covariables included the number of implants used, production batch number of the implants, the operator, as well as other demographic and medical factors. RESULTS: In the wash group, the extrusion rate was 12% per procedure (19 pellets from 15 subjects) whereas in the control group, the extrusion rate was 11.1% per procedure (18 pellets from 14 subjects), indicating no evidence of any benefit of the wash procedure (OR = 1. 09 [95% CI 0.47-2.6] per procedure). There was no evidence of benefit in secondary endpoints including total adverse events (7.1%, OR 1.28 [0.44-3.9], bleeding/bruising (8.8%, 1.23 [0.47-3.3]) and infection (4.0%, 1.54 [0.35-7.6]) per procedure. Among men reporting an infection requiring antibiotic treatment according to their own general practitioners, six/ten (60%) subsequently experienced an extrusion. There were no significant differences in extrusion rate between four different operators (P = 0.24) nor among 12 different batches of pellets used during the course of the study (P = 0.77). CONCLUSIONS: The pellet washing procedure used during implantation does not reduce the subsequent extrusion rate. The higher rate of both primary and secondary adverse events in this prospective study compared with the previous retrospective survey may reflect either more rigorous follow-up or a secular trend. 相似文献
108.
109.
Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel
Hirsch MS Brun-Vézinet F Clotet B Conway B Kuritzkes DR D'Aquila RT Demeter LM Hammer SM Johnson VA Loveday C Mellors JW Richman DD;International AIDS Society-USA Resistance Testing Guidelines Panel 《Topics in HIV medicine : a publication of the International AIDS Society, USA》2003,11(4):150-154
In 1996 the International AIDS Society-USA convened an international panel of experts in HIV drug resistance and clinical management to develop guidelines for the clinical use and limitations of resistance testing. Since then the International AIDS Society-USA Resistance Testing Guidelines Panel has developed and regularly published its recommendations. The latest panel recommendations appear in the July 1 issue of Clinical Infectious Diseases. We periodically pose questions to the panel relating to clinical elements of resistance testing that have been collected from HIV practitioners across the nation. We are happy to feature the latest edition in this issue of Topics in HIV Medicine. It is our hope that addressing these issues will help guide your treatment strategy decisions regarding resistance testing. 相似文献
110.